Inner-City Asthma Consortium Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2017
NCT03292588
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Inner-City Asthma Consortium

Active Ingredients

Drugs in Phase 2 Trials (2)

german cockroach allergen extract (1 trial)

mepolizumab (Nucala) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2